Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Masimo's (MASI) W1 Medical Watch to Boost Patient Monitoring
12:02pm, Monday, 20'th Nov 2023
Masimo's (MASI) receipt of the latest FDA approval is expected to provide greater visibility of changes in oxygen saturation to help patients better manage their oxygen levels daily.
Masimo's (MASI) Latest Tie-Up to Boost Patient Monitoring
12:47pm, Tuesday, 14'th Nov 2023
Masimo's (MASI) latest joint effort is likely to enable real-time continuous monitoring with a tailored view of the patient's vitals while keeping them mobile during critical recovery periods.
Masimo Corporation (MASI) Q3 2023 Earnings Call Transcript
10:44pm, Tuesday, 07'th Nov 2023
Masimo Corporation (NASDAQ:MASI ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development and Investor Relations Joe Kian
Compared to Estimates, Masimo (MASI) Q3 Earnings: A Look at Key Metrics
09:02pm, Tuesday, 07'th Nov 2023
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Stre
Apple's response to patent ruling is 'loaded and outrageous', says Masimo CEO
05:21pm, Friday, 27'th Oct 2023
Joe Kiani, Masimo CEO, joins 'Closing Bell Overtime' to talk its legal win over Apple, Apple's response, what's next for Masimo and more.
Masimo Corp boosted with patent win over Apple Watch
09:34am, Friday, 27'th Oct 2023
Masimo Corp (NASDAQ:MASI), a maker of patient monitoring devices and wearable tech, saw its stock surge higher in Friday's early deals as it was handed a significant win in its patent dispute with App
Masimo (MASI) Gets De Novo for Novel Oxygen Status Index ORi
08:16am, Monday, 16'th Oct 2023
Masimo's (MASI) ORi parameter gets De Novo from the FDA, providing option for continuous monitoring of oxygen level in surgical patients leading to better management of hyperoxia.
Masimo's (MASI) LiDCO to Boost Hemodynamic Monitoring Post CE Mark
01:33pm, Tuesday, 10'th Oct 2023
Masimo's (MASI) LiDCO is likely to offer clinicians a BIC solution designed to provide a more complete picture of oxygen delivery.
Masimo: Lots Of Questions
05:54pm, Monday, 25'th Sep 2023
Masimo Corporation shares fell after announcing a "diworsification" move for Sound United, causing concerns about the company's core expertise. Despite a recovery in share price, the company's second
Masimo's (MASI) Inks Agreement to Improve Patient Outcomes
12:49pm, Friday, 01'st Sep 2023
Masimo's (MASI) latest deal with FMOLHS is expected to enhance patient safety and improve patient outcomes.
Masimo's (MASI) PVi Favored by Study for GDFT in Elderly Patients
02:17pm, Tuesday, 22'nd Aug 2023
Masimo's (MASI) non-invasive, continuous PVi is expected to reduce cardiopulmonary complications and fluid administered in elderly patients during GI surgery.
Masimo (MASI) Q2 Earnings Lag Estimates, Margins Rise
02:27pm, Wednesday, 09'th Aug 2023
Despite strength in Hearables category, Masimo's (MASI) overall second-quarter results reflect soft performances.
Masimo (MASI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
10:41pm, Tuesday, 08'th Aug 2023
The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Masimo Corporation (MASI) Q2 2023 Earnings Call Transcript
09:59pm, Tuesday, 08'th Aug 2023
Masimo Corporation (NASDAQ:MASI ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Eli Kammerman - VP, Business Development & IR Joseph Kiani - Founder, CEO & Chairman M
Masimo (MASI) Q2 Earnings Miss Estimates
07:42pm, Tuesday, 08'th Aug 2023
Masimo (MASI) came out with quarterly earnings of $0.62 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $1.35 per share a year ago.
